Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Equity Ratio (2023 - 2026)

Cannabis Bioscience International Holdings' Equity Ratio history spans 4 years, with the latest figure at 950.21 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 1054.13% to 950.21 in Q1 2026 year-over-year; TTM through Feb 2026 was 950.21, a 1054.13% decrease, with the full-year FY2025 number at 36.5, down 93.36% from a year prior.
  • Equity Ratio hit 950.21 in Q1 2026 for Cannabis Bioscience International Holdings, down from 61.6 in the prior quarter.
  • Over the last five years, Equity Ratio for CBIH hit a ceiling of 8.27 in Q4 2023 and a floor of 950.21 in Q1 2026.
  • Historically, Equity Ratio has averaged 118.46 across 4 years, with a median of 32.64 in 2024.
  • Biggest five-year swings in Equity Ratio: tumbled 38.41% in 2024 and later plummeted 1054.13% in 2026.
  • Tracing CBIH's Equity Ratio over 4 years: stood at 8.27 in 2023, then tumbled by 294.87% to 32.64 in 2024, then tumbled by 88.7% to 61.6 in 2025, then tumbled by 1442.64% to 950.21 in 2026.
  • Business Quant data shows Equity Ratio for CBIH at 950.21 in Q1 2026, 61.6 in Q4 2025, and 65.79 in Q3 2025.